Evidence map›Paper›PMID 42560666›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2026

NIR-Assisted Multimodal Strategies for Enhanced Antibacterial Therapy.

Mei Fang, Shu Gao, Jun Wang, Yongxin Ma, Qi Liu, Haonan Wu, Kun Qian, Zhen Cheng

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mei FangSchool of Pharmacy, Nanchang University, Nanchang, China.ORCID https://orcid.org/0009-0008-4285-7826
Shu GaoState Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institue of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Jun WangState Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institue of Materia Medica, Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0009-0001-0434-8747
Yongxin MaState Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institue of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Qi LiuState Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institue of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Haonan WuState Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institue of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Kun QianState Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institue of Materia Medica, Chinese Academy of Sciences, Shanghai, China.ORCID https://orcid.org/0000-0003-1998-0806
Zhen ChengSchool of Pharmacy, Nanchang University, Nanchang, China.ORCID https://orcid.org/0000-0001-8177-9463

Funding

National Natural Science Foundation of China U2267221Shandong Laboratory Program SYS202205Strategic Priority Research Program of the Chinese Academy of Sciences XDB0830300
6 · The paper itself

Abstract

Bacterial infections, particularly those caused by multidrug-resistant pathogens and biofilm formation, have significantly undermined the efficacy of conventional antibiotics, highlighting the urgent need for novel antibacterial strategies. NIR-driven photothermal (PTT) and photodynamic therapies (PDT) have emerged as promising non-antibiotic approaches due to their noninvasive nature and precise spatiotemporal controllability. However, single-modality NIR treatments remain constrained by potential thermal damage to healthy tissues and reduced efficacy within the infection microenvironment. To address these limitations, researchers have developed NIR-mediated multimodal strategies that integrate complementary mechanisms for synergistic antimicrobial effects. Despite increasing studies, a systematic overview of NIR-based synergistic antibacterial strategies remains lacking. This review provides the first comprehensive focus on the combined application of NIR-mediated PTT/PDT with gas therapy (GT), chemodynamic therapy (CDT), immunotherapy, antibiotic adjuvants, and sonodynamic therapy (SDT). We summarize recent advances, discuss how these approaches overcome resistance, disrupt biofilm barriers, enhance antibacterial efficiency, and promote wound healing, and highlight the current challenges and prospects for clinical translation in this rapidly evolving field.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsInfrared RaysAnimalsBiofilmsCombined Modality TherapyHumansPhotochemotherapyAnti-Bacterial Agentsantibacterialmultimodal therapyNIR

Identifiers

PMID42560666
PMCPMC13568891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.